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AbsTrACT
The childhood condition of visual difficulties caused by 
brain damage, commonly termed cortical or cerebral 
visual impairment (CVI), is well established but has 
no internationally accepted definition. Clarification 
of its core features is required to advance research 
and clinical practice. This systematic review aimed to 
identify the definitions of childhood CVI in the original 
scientific literature to describe and critically appraise 
a consensual definition of the condition. MEDLINE, 
EMBASE, PsychINFO, CINAHL and AMED databases 
were searched in January 2017. Studies were included if 
they (1) were published original research, (2) contained 
a childhood CVI sample, (3) contained a definition of 
CVI and (4) described their CVI identification/diagnostic 
method. Thematic analysis identified concepts within 
definitions and narrative synthesis was conducted. Of 
1150 articles, 51 met inclusion criteria. Definitions were 
subdivided according to detail (descriptive definition, 
description not reaching definition status and diagnostic/
operationalising criteria). Three themes concerning visual 
deficits, eye health and brain integrity were identified 
(each containing subthemes) and analysed individually 
across definitions. The most common themes were 
‘visual impairment’ (n=20), ’retrochiasmatic pathway 
damage’(n=13) and ’normal/near normal eye health’ 
(n=15). The most consensual definition identified 
here may not be the best quality for advancing our 
understanding of CVI. We argue for the alternative 
definition: CVI is a verifiable visual dysfunction which 
cannot be attributed to disorders of the anterior 
visual pathways or any potentially co-occurring ocular 
impairment. We propose reporting guidelines to permit 
comparison across studies and increase the evidence 
base for more reliable clinical assessment and diagnosis.
InTroduCTIon
Brain injury is the most common cause of severe 
visual impairment in the UK,1 yet ‘cerebral visual 
impairment’ as an entity remains vague. Affected 
children often have other impairments such as intel-
lectual disability, movement disorders and epilepsy 
and are likely to be assessed and managed by a wide 
range of professionals (including ophthalmologists, 
paediatricians, neurologists, psychologists and other 
allied healthcare professionals).2–10 Therefore, clarity 
and agreement over what cerebral visual impairment 
means will improve communication and management.
The term cerebral or cortical visual impairment 
(CVI) refers to visual impairment or dysfunction 
originating in neural insult.11 12 The pathology 
of childhood CVI is established; however, subtly 
different terminologies and definitions are applied 
to this disorder, which influence the selection of clin-
ical assessment methodologies.13 14 In children with 
the classic presentation of visual acuity reduction in 
the absence of anterior pathway damage and a clin-
ical history or direct indication of neural damage, 
clinical diagnosis may be relatively straightforward. 
However, in addition to visual impairment (signifi-
cantly reduced visual acuity and/or visual fields15), 
the inclusion of a broad range of other indicators 
such as wider visual and ocular dysfunctions in CVI 
is commonly debated.2 3 13 14 16–21 For example, a 
child with severe intellectual and mobility impair-
ments may show poor visual responses, but it can 
be difficult to ascertain whether this is due to 
global impairment or a specific visual deficit. This 
may be further complicated by co-occurring ocular 
pathology such as optic atrophy. Alternatively, a 
child with known brain injury confirmed by MRI 
may show relatively good visual acuity but severe 
difficulties in functional use of vision in everyday 
life (such as interpreting crowded visual scenes, 
visuomotor control or route-finding), with visual 
perceptual impairment confirmed by neuropsycho-
logical assessment. Equally, a child with the above 
symptoms may not have a medical history or MRI 
evidence of brain injury. Cases such as the examples 
above may warrant and benefit from a diagnosis of 
CVI and implementation of management strate-
gies. In children with more complex presentations, 
it is difficult to know where to set the boundaries 
of the condition and whether to ascribe difficulties 
to CVI or other developmental conditions.16 This 
has led to the debated proposal that there must be 
sufficient discrepancy between cognitive and visual 
perceptual quotients to establish a visual processing 
deficit.22–26 The suspicion of neural damage is also 
often difficult to confirm clinically,13 27 leading a 
recent systematic review exploring the visual percep-
tual dysfunctions of childhood CVI to conclude that 
the definition should be based on functional vision 
rather than neuroanatomical landmarks.13
To advance the understanding of childhood CVI 
for diagnostic and nosological purposes, clarifica-
tion of its core features is recommended.14 28 This is 
important for guiding clinicians in selecting age-ap-
propriate and developmentally appropriate assess-
ments for more accurate diagnosis.13 28 29 However, 
as there is currently no international consensus on 
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the definition of childhood CVI which covers the range of child-
hood developmental abilities and age, there is consequently no 
universally accepted diagnostic assessment framework.30 The 
diagnostic process may be based on ophthalmological examina-
tion, basic vision examination, standardised neuropsycholog-
ical assessment, neuroimaging or any combination of these. No 
guidelines exist on which professionals can or should be qual-
ified to make a clinical diagnosis of the condition. Moreover, 
there are only a few evidence-based interventions, of limited 
scope, for childhood CVI, as it is difficult to evaluate potential 
treatments in the absence of a stable reference standard.31
Previous efforts to reach an international consensus on the 
definition of childhood CVI have been undertaken by round 
table discussion by expert clinicians and researchers.12 32 33 An 
alternative approach is to systematically scrutinise those defini-
tions used in empirical studies of CVI. This will permit a critical 
examination of definitions already in use. To the authors’ knowl-
edge, such a systematic investigation has not yet been conducted. 
There are known to be multiple assessment approaches for 
testing CVI,3 34 35 but consideration of their usefulness and how 
they correspond with the definitions identified is beyond the 
scope of this review.
The aim of this systematic review is to identify and critically 
evaluate the terminologies and definitions of childhood CVI 
in the published peer-reviewed scientific and medical litera-
ture, thereby identifying if there is a consensual definition of 
childhood CVI in current practical use and the nature of such a 
definition.
MeThod
search strategy
The literature search was run in the Ovid MEDLINE, Embase 
Classic+Embase, PsycINFO, CINAHL and AMED databases in 
January 2017 by one author (HEAS) after development of the 
search strategy by three authors (HEAS, NJD and TP-R). All free-
text terms and subject headings relating to CVI and childhood 
were used. Searches were restricted to original peer-reviewed 
research articles and the grey literature was excluded. No publi-
cation time limits were applied as this is a relatively new field of 
research with no previous consensus or systematic evaluation, 
and any possible effects of time on definitions and terminolo-
gies used were not known. A manual search was performed on 
four textbooks of childhood CVI.32 36–38 The results were stored 
in EndNote X7, and duplicates were removed. The reference 
lists of included articles were inspected manually for previously 
unidentified references. Only English language articles were 
included as there was no capacity for translation. See supple-
mentary materials for full search details (online supplementary 
table 1).
Inclusion/exclusion criteria and process
Titles and abstracts were independently reviewed by two 
researchers (HEAS and TP-R). When there was insufficient detail 
to determine eligibility, the full text was obtained. Full texts 
were reviewed independently by the researchers. Articles were 
included if they (1) were original research papers published in 
peer-reviewed scientific journals, (2) contained a childhood CVI 
sample (aged 0–19 years), (3) contained a definition of CVI and 
(4) contained descriptions of the methods used to identify chil-
dren with CVI/allocate children into the CVI group. Disagree-
ments at both stages were resolved by discussion between 
reviewers.
data extraction
A data extraction tool was designed for this review concerning 
(1) demographics and identification of the articles, (2) termi-
nology and definitions of CVI and (3) methodological informa-
tion and sample characteristics (see supplementary materials: 
online supplementary table 2 for full definitions, online supple-
mentary tables 3 and 4 for methodological details).
data analysis
Qualitative analysis was conducted to identify the characteristics 
that were included in the descriptive definitions and diagnostic/
operationalising criteria of CVI. Quantitative analysis of these 
characteristics was run to find the prevalence of components and 
summarise findings in a narrative synthesis.
Thematic analysis
Thematic analysis was conducted to analyse the content of defi-
nitions. This is a six-step qualitative method used to identify, 
analyse and report patterns within data.39 Similar approaches 
have previously been used to analyse definitions in healthcare 
research.40 41 Definitions and diagnostic/operationalising criteria 
were analysed separately. All definitions and diagnostic/opera-
tionalising criteria were extracted as data codes for inductive 
identification of themes. Data codes were split and organised 
according to themes within definitions and diagnostic/oper-
ationalising criteria. They were reviewed to identify possible 
subthemes and then rereviewed. Themes and subthemes were 
named and described. Themes and subthemes were rereviewed 
at the final stage to check that codes were correctly categorised. 
A second researcher independently coded 20% of data for inter-
rater reliability. Cohen’s Kappa was 0.85, indicating an excellent 
level of agreement.42
Quality assessment
Quality of the included studies was assessed by the level of detail 
in each definition. Definitions of CVI were subdivided into three 
groups on the basis of detail provided. The ‘descriptive defini-
tion’ was classified as a statement which explicitly or implicitly 
described the core characteristics of CVI. In most papers. the 
definition of CVI was clearly identified with phrases such as 
‘(CVI) is defined as…’17 20 43–46 or ‘(CVI) is a clinical syndrome 
manifested by…’.47 These were taken to be explicit definitions. 
However, in some cases. there was no explicit definition of CVI 
in a single phrase.30 48 These were considered ‘descriptions not 
reaching definition status’ as it was unclear whether they were a 
more general description or a narrower definition of CVI to suit 
a specific study or sample. ‘Diagnostic/operationalising criteria’ 
were often similar to the descriptive definition but were classified 
as explicit statements of how the participants were diagnosed 
or allocated into the CVI group. Examples of how such criteria 
were identified are ‘CVI was diagnosed clinically…’,49–53‘…clin-
ical characteristics consistent with CVI…’30 and ‘…diagnosis of 
CVI was based on…’.43 Most articles contained both a descrip-
tive definition of CVI (either explicit definition or implicit 
description not reaching definition status) and diagnostic/oper-
ationalising criteria for CVI. Both data sets were extracted in 
these cases, as these often differed.
A quality assessment tool was designed for this review. Studies 
were assessed for whether the definition of CVI provided was 
explicit and whether the definition and diagnostic or operation-
alising criteria matched if both were reported. Studies which had 
an explicit descriptive definition, diagnostic/operationalising 
criteria and where the elements of the definition and diagnostic/
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operationalising criteria matched were rated as good quality. 
Studies which only had an explicit descriptive definition but 
no diagnostic criteria were rated as medium quality. Studies in 
which the elements of the definition and diagnostic criteria did 
not match or which only had operationalising/diagnostic criteria 
or a description not reaching definition status were rated as poor 
quality.
resulTs
Article characteristics
Figure 1 shows the PRISMA diagram of the review process. 
Fifty-one articles included a descriptive definition or diagnostic/
operationalising criteria of CVI and were included (table 1). 
Although several papers were published by the same research 
groups, definitions of CVI varied between the papers. Seven 
papers published data from children at the VI programme at the 
Children’s Hospital Vancouver, Canada,4 30 45 54–57 six from the 
Wilhelmina Children’s Hospital Utrecht, the Netherlands,58–60 
three from the University of Pisa, Italy,18 61 62 two from a Paedi-
atric Ophthalmology Unit in San Francisco, USA5 9 and two from 
the Bartimeus Institute, the Netherlands.49 53 Other articles may 
have also published on overlapping samples but all studies did 
not report their recruitment sources in enough detail to recog-
nise this. It was not possible to identify exactly articles that 
reported data on the same or overlapping samples where several 
publications by single research groups fulfilled the inclusion 
criteria. Thus, all eligible articles were included in the analysis.
Thirty-three articles (65%) included both a descriptive defi-
nition and diagnostic/operationalising criteria, eight (16%) 
included only a descriptive definition and ten (20%) included 
only diagnostic/operationalising criteria. Of the 41 papers 
containing descriptive definitions, 35 (85%) had explicit defi-
nitions and 6 (15%) had ‘descriptions not reaching definition 
status’. According to quality assessment, 4 papers had good 
quality, 8 had medium quality and 39 had poor quality defini-
tions (table 1).
The studies covered a range of populations, including children 
at risk of CVI, specific subgroups with diagnosed CVI and general 
CVI samples (see supplementary materials, online supplemen-
tary table 3). In 34 articles, CVI had been diagnosed before the 
study and in 17 there was an explicit diagnosis or allocation of 
children to the CVI group. In 47 articles, CVI was diagnosed 
on the basis of reduced visual acuity and in  4 articles on the 
basis of wider visual dysfunction (online  supplementary table 3). 
Forty-seven articles (92%) reported sample size, with CVI-only 
samples ranging between 2 and 423 participants (mdn=34). 
Median gender distribution, reported in 23 studies (45%), was 
55% boys (range 38–78% boys). Twenty-nine studies (60%) 
reported participant age, ranging between 0 and 45 years. Four 
studies (9%) that included single participants over 19 years (aged 
45, 35, 25 and 20 years) were included as they were part of large 
childhood samples. Participants in the included studies were 
reported to have a number of comorbidities, including intellec-
tual disability, movement disorder, seizure disorder, hydroceph-
alus, hearing impairment and other conditions (supplementary 
materials, online supplementary table 4). However, no articles 
explicitly considered how to diagnose CVI in the context of 
other conditions.
Studies used a variety of methods to assess for and diagnose 
CVI (supplementary materials,  online supplementary table 4). 
In 25 studies, the assessor was not reported. Sixteen studies 
partially reported the assessors or had only one professional 
assessing the participants. Ten studies reported assessment by a 
multidisciplinary team, three of which did not detail the team 
members. There were different professionals involved in the 
assessments of different studies, including ophthalmologists, 
paediatricians, neurologists, psychologists and other allied 
health professionals (online supplementary table 4). In their 
methods, 19 studies explicitly reported fundus examination, 
19 explicitly reported refraction and 20 explicitly reported 
an ocular motility assessment. A variety of vision assessments 
were reported, including visual acuity (n=34), very low vision 
(n=16), visual fields (n=15), neuropsychological (n=4 assessed, 
n=7 attempted), contrast sensitivity (n=3) and stereopsis (n=2). 
Twenty-eight studies conducted visual electrophysiology assess-
ment. Thirty-one studies reported conducting a neuroimaging 
assessment, including MRI, CT, cranial ultrasound and PET. Due 
to incomplete reporting of exact tests used, it was not possible 
to identify specific clinical assessments that may be used more 
widely in the identification of childhood CVI and systematic 
evaluation of assessments is beyond the scope of this review. 
In 25 articles, the assessor conducting the examination was not 
reported.
Terminology
Table 2 describes the geographical distribution of research groups 
and CVI terminologies used. Articles were published between 
1979 and 2016 (table 1). The most prevalent terminology 
was cortical visual impairment (43% of all papers), used most 
commonly in North America (67% of North American papers). 
The terminology most used by European research groups was 
cerebral visual impairment (41% total, 83% of European papers). 
Other terminologies identified were cortical blindness, cerebral 
blindness, central visual impairment, cerebral visual disturbance 
and retrogeniculate visual loss. These were used by eight papers 
(16%), the majority published before 2000.
definitions of CVI
Thematic analysis revealed three consistently occurring themes 
within the definitions of CVI (table 3). Eleven papers (27% of 
all definitions) had definitions containing all three themes and 
were all rated as having explicit definitions. Theme combina-
tions within definitions were very heterogeneous, thus themes 
Figure 1 PRISMA diagram of literature review process. CVI, cortical or 
cerebral visual impairment.
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were considered separately. The most common theme was Vision 
Deficits (in 90% of definitions) and contained three subthemes, 
of which visual impairment (according to WHO classification15) 
was the most prevalent (54% of subthemes). The theme of Eye 
Health (in 51% of definitions) contained three subthemes, of 
which eye health normal/near normal (eg, ‘normal or minimal 
ocular findings’57) was the most prevalent (71% subthemes). The 
theme of Brain Integrity theme (present in 76% of definitions) 
contained six subthemes, of which retrochiasmatic pathway 
damage was the most prevalent (42% subthemes).
diagnostic criteria of CVI
In the 43 studies detailing diagnostic/operationalising criteria 
(84% of all papers), 10 (23% criteria) mentioned all three content 
themes of CVI in different combinations (table 3). The most 
commonly occurring theme was Vision Deficits (95% criteria), 
with its most common subtheme being visual impairment (70% 
subthemes). The most common subtheme of Eye Health (93% 
criteria) was eye health normal/near normal (51% subthemes). 
Brain Integrity was only present in 28% of diagnostic/operation-
alising criteria, with the most common subtheme being posterior 
visual pathway damage (42% criteria).
dIsCussIon
This systematic review found commonality and diversity in 
the terminologies and definitions of childhood CVI, indicating 
some but not total consensus. Terminologies varied according to 
geographical location similarly to previous reports.11 12 20Cere-
bral and cortical visual impairment were most commonly used, 
the former in Europe and the latter in North America. Other 
terms showed no particular geographical patterns. Older terms 
such as Cortical Blindness are no longer used widely. They are 
not considered to represent CVI accurately as they imply total 
loss of vision, whereas most children with CVI show some 
preserved visual function.2 55 63 The overall consensus points 
towards use of the term Cerebral visual impairment or Cortical 
visual impairment. We argue that the term cerebral is more suit-
able than cortical to describe CVI as subcortical damage to the 
posterior visual pathways is a common and accepted cause of the 
condition.27 64 65 The older term cortical continues to be used in 
North America; however, researchers may be moving towards 
using cerebral for a more precise description.11 12 29 52 66 67 Even 
researchers using the alternative term acknowledge that the term 
cerebral may most accurately describe the breadth of neural 
insults causing this condition.6 11
Diversity was found in the content of CVI descriptive defi-
nitions, in accordance with previous literature.13 66 68 Although 
three core characteristics of CVI were identified, relating to 
visual deficits, eye health and brain integrity, the majority of 
definitions did not include all three characteristics. Based on this 
analysis, the most consensual definition of all three characteris-
tics was a visual impairment caused by damage to the retrochias-
matic pathways with normal/near normal eye health. Diagnostic/
operationalising criteria showed similar characteristics with 
one significant omission. The two most prevalent diagnostic/
operationalising criteria were visual impairment in the context 
of normal/near normal eye health; few papers mentioned Brain 
Integrity.
This analysis has highlighted issues which may need to be 
addressed for a clinically useful definition of childhood CVI. 
First, although the term visual impairment is well accepted, there 
has been a question of whether it is sufficiently wide to describe 
the range of visual difficulties described in the population. Many A
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children with CVI appear to have greater difficulty in everyday 
visual behaviours than is explained by visual acuity.16 19 55 69 
Some have argued that the descriptor of a ‘broad spectrum of 
visual dysfunctions’ may better align with the recommenda-
tions of the WHO, the International Council of Ophthalmology 
and recent research suggesting that assessing vision difficulties 
should be based on wider visual function rather than visual 
acuity/field assessment alone and impairment alone.13 70 71 A 
related debate is the issue of what is included in the term ‘visual 
impairment’. The International Classification of Diseases-1015 
refers to significant visual acuity and/or visual field reduction 
but there have been calls to expand the term to include wider 
visual deficits.3 13 16 19 Many children at risk of CVI with normal 
visual acuities show significant visual perceptual difficulties 
which affect daily living.17 19 69 The question remains: should 
they be diagnosed with CVI? If childhood CVI does encompass 
wider visual dysfunctions, further subclassification of the condi-
tion may be very important to ensure a meaningful diagnosis 
and appropriate support for the individual child. Of relevance, 
ICD-11 beta versions (http:// apps. who. int/ classifications/ icd11/ 
browse/ f/ en) do now include more functional descriptors such 
as ‘Visual spatial neglect’, ‘Prosopagnosia’ and ‘Dysfunction of 
reading ability’ under the headings of ‘Specific visual dysfunc-
tions’ and ‘Complex vision-related dysfunctions’.
Second, the description of no/minimal eye involvement may 
not be accurate as some ocular pathology is commonly reported 
in CVI.18 64 67 72 73 For example, an ophthalmologist (author 
RB of this review) recently declined to operate on a child with 
dense cataracts because there was evidence of blindness from 
brain damage predating this, the cause of which was deemed 
CVI although eye health was not normal. A more appropriate 
description may be that ‘any degree of ocular/anterior pathway 
damage present cannot explain the degree of visual dysfunction’. 
This ensures that CVI is not overlooked in children with ocular/
anterior pathway damage and conversely that the ocular needs 
of children with CVI are not neglected.
Finally, this review showed that the descriptions of Brain Integ-
rity were the most limited in definitions and diagnostic criteria. 
The more accepted description of retrochiasmatic pathway 
damage gives minimal detail of the possible areas of brain 
damage. Current clinical neuroimaging methods may or may not 
show abnormalities in the presence of definite behavioural symp-
toms and clinical information supporting diagnosis.13 27 New 
experimental methods may reveal subtle morphological brain 
differences but these require powerful imaging and intensive data 
analysis, which are not feasible in current clinical practice.74–77 
This raises the question of how brain damage is clinically defined. 
For example, children born preterm may have elevated levels of 
visual perceptual difficulties even with MRI scans reported as 
normal27; is a known risk factor sufficient? Currently, the compo-
nent of Brain Integrity is only inferential and assumes that clinical 
visual symptoms originate at brain level. The appropriate diag-
nosis of children with significant visual perceptual deficits but no 
apparent neurological insult remains a challenge.
Table 2 Geographical locations of research groups and cerebral or cortical visual impairment (CVI) terminologies used
Geographical location of research group Terminology
Continent (n) Country (n) City/state (n)
Cerebral visual 
impairment (n=21)
Cortical visual 
impairment (n=22) other (n=8)
North America (24) Canada (8) Vancouver (7) 2 16 6
Toronto (1)
USA (16) New York (2, 1*)
San Francisco (5, 1*)
Los Angeles (1)
Philadelphia (2)
Missouri (1)
Minnesota (1)
Arkansas (1)
Nashville (1)
Europe (18) Belgium (1) Leuven (1) 15 1 2
Italy (5) Pavia (3)
Pisa (2†)
The Netherlands (11) Amsterdam (2)
Nijmegen (2)
Utrecht (5, 1*)
Rotterdam (1)
Turkey (1) Izmir (1)
Asia (5) Hong Kong (2) Hong Kong (2) 1 4 –
India (1) Bangalore (1)
Japan (1) Sendai (1*)
South Korea (1) Seoul (1)
Middle East (2) Israel (2) Ramat Gan (1‡) 1 1 –
Haifa (1‡)
Oceania (1) New Zealand (1) Auckland (1) 1 – –
South America (1) Brazil (1) Sao Paolo (1) 1 – –
*Children recruited from this area and corresponding author based in this area, collaborating authors based in other regions nationally.
†Children recruited from this area and corresponding author based in this area, collaborating authors based in other regions internationally.
‡Children recruited from other regions nationally and corresponding author based in this area, collaborating authors based in other regions nationally.
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In light of this review, we propose the following definition of 
childhood CVI, argued above: childhood cerebral visual impair-
ment is a verifiable visual dysfunction which cannot be attributed 
to disorders of the anterior visual pathways or any potentially 
co-occurring ocular impairment. We suggest that the components 
of this definition are measurable and may be quantified using 
currently available clinical tools. A multidisciplinary approach 
to clinical assessment of childhood CVI may be valuable in cases 
where the ophthalmologist working on their own is unable to 
reach a diagnosis. Multidisciplinary input might involve full 
vision assessment, structured paediatric history. including vision 
and general development, full ophthalmological examination 
and clinical neuroimaging (although it might be appropriate to 
defer this for a baby who would require a general anaesthetic 
for MRI and for whom the MRI findings are unlikely to change 
medical management). Neuropsychological assessment of cogni-
tion and higher visual processes could also be informative if 
visual perceptual impairment is suspected. However, multidis-
ciplinary assessment may not be feasible in all clinical services. 
Assessment should always be conducted with the principal aim 
of improving the understanding of the child’s visual needs and 
limitations and helping to establish appropriate management 
strategies in a timely manner.
The limitations of this review must be considered when 
interpreting results. The inclusion of potentially overlapping 
samples across studies and several publications by the same 
research groups may have biased findings towards the views of 
more prolific researchers. However, definitions and diagnostic 
criteria of groups were not constant across studies, thus selec-
tion bias from these groups is unlikely. Although many articles 
were medical case note reviews, this analysis was based only on 
empirical research and may not reflect the full range of clinical 
practice or expert opinion. It will be important to ensure that a 
future consensual definition is clinically useful and applicable. 
Other developmental considerations of CVI not identified here 
may be important to address, such as the impact of age of onset 
(childhood or adulthood), which may lead to differing symptom 
presentations and outcomes.2 5 54 78–80 Another possibly relevant 
feature is aetiology, such as the difference between congen-
ital and later acquired CVI from infection, trauma or brain 
tumour, which may affect the brain damage, visual difficulties 
and comorbidities seen.5 53 80 81 A related consideration is how 
to best describe the heterogeneous symptomatology of CVI. 
In future. consensus may move towards a classification system 
with subgroups within the umbrella term of CVI,3 depending on 
further empirical research. However. divisions into subgroup-
ings may not yet be feasible due to our limited understanding of 
the condition.13
As our empirical understanding of childhood CVI increases, 
the content of the definition will be guided by new findings66 
which may lead to more reliable clinical assessment and diag-
nostic procedures. There is an emerging tendency towards multi-
disciplinary assessment, including clinical history-taking,3 69 
neuropsychology17 18 27 and visual electrophysiology,34 51 82 in 
the clinical identification of visual, neuropsychological and 
neurological symptoms which may be part of the CVI presenta-
tion. However, within the context of limited consensual defini-
tion and diagnostic procedures shown in this systematic review, 
clinicians and researchers will continue to draw on individual 
means of assessing and diagnosing the condition. As 77% of arti-
cles included in this analysis contained poor quality definitions, 
detailed reporting of methodologies is a necessity for future 
research. At minimum, research publications should always 
report the sample characteristics, descriptive definition and diag-
nostic or operationalising criteria of CVI as well as their exact 
assessment methods of CVI, to permit comparison across studies 
and increase the evidence base of the condition.
In summary, the consensual definition found in this review 
suggests that childhood CVI is a visual impairment caused by 
damage to the retrochiasmatic pathways with normal/near 
Table 3 Process and results of thematic analysis
Process of thematic analysis results of thematic analysis
Initial 
identification of 
themes
review of 
themes
rereview and naming/
defining themes Identification of subthemes
descriptive definitions, n=41
explicit definition, n=35 (dnrds*, 
n=6)
diagnostic/
operationalising 
criteria, n=43
Themes subthemes Themes subthemes
1. Vision 1. Vision 1. Vision Deficits
Any references to difficulties 
with the conscious 
perception of vision
1. Complete blindness 35 (2*) 5 42 4
2. Visual acuity reduction/visual 
impairment
19 (1*) 30
3. Visual dysfunction 11 (1*) 8
2. Eye health normal 2. Eye health 
(including 
inconsistent 
vision eye 
health)
2. Eye Health
Any reference to the health 
of the ocular structures or 
the anterior visual pathways
1. Eye health normal/near normal 20 (1*) 14 (1*) 40 22
3. Inconsistent 
vision eye health
2. Eye problems do not account for the 
extent of vision problems
6 18
4. Brain 3. Brain 3. Brain Integrity
Any mention of brain or 
neural involvement
1. Brain damage 25 (5*) 2 12 0
2. Posterior visual pathway damage 8 (1*) 5
3. Optic radiation damage 1 (1*) 0
4. Retrochiasmatic pathway damage 11 (1*) 2
5. Retrogeniculate pathway damage 3 4
6. Posterior pathway damage, 
including higher processing/
association areas
0 (2*) 1
5. Paediatric
6. Miscellaneous (including aetiologies, assessment methods)
*DNRDS, description not reaching definition status.
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normal eye health. However, we argue for an alternative defi-
nition based on research findings, expert opinion and clinical 
applicability that childhood CVI is a verifiable visual dysfunc-
tion which cannot be attributed to disorders of the anterior visual 
pathways or any potentially co-occurring ocular impairment. 
Diagnostic/operationalising criteria have been stronger in rela-
tion to characterising visual deficits and eye health than in rela-
tion to brain integrity. It has been argued that future definitions 
and diagnostic criteria may need to expand further to encompass 
the wide spectrum of children presenting in clinical ophthal-
mology services with suspected CVI, including those with higher 
visual processing dysfunctions but relatively intact visual acuity. 
Accurate identification of CVI in children with complex devel-
opmental presentations remains a major challenge for clinical 
diagnosis and treatment. Due to the lack of a unified definition 
and diagnostic process, children may receive very different clin-
ical care and interventions depending on the clinical service they 
attend, both internationally and at a national level. This review 
proposes that further work is required for an internationally 
accepted consensus in definition for CVI to reflect advances 
in thinking about childhood CVI and to underpin future clin-
ical and research developments. As previous expert round table 
discussion12 32 33 and now systematic scrutinising of terminolo-
gies, definitions and diagnostic criteria have been completed, the 
next stage of furthering such a consensus requires advances in 
empirical investigations to consider whether a more refined defi-
nition and classification system of CVI is required.
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